Key Insights

Highlights

Treatment Research

2 treatments under study, led by Petct

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02511197Early Phase 1UnknownPrimary

68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis

Showing all 1 trials

Research Network

Common Treatments

  • Petct1
  • 68ganotaprgd21

Active Sponsors

  • Peking Union Medical College Hospital1

Top Investigators

Activity Timeline